A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Alone and in Combination for the Treatment of Overactive Bladder (Symphony)

Sponsor and Collaborators
Astellas Pharma Inc

Contact
Global Clinical Science
+ 31 (0)71 54 55 878
contact@nl.astellas.com

Global Medical Science
+ 31 (0)71 54 55 878
contact@nl.astellas.com

Principal Investigator
Astellas Pharma Europe BV
Bristol Urological Institute

ClinicalTrials.gov Identifier
NCT01340027